Sarepta pushes back Elevidys timeline; Emergent lays off 90 staffers
๐๏ธ Sarepta Therapeutics delays readout of non-ambulatory Elevidys study: The company previously said the study would read out by year end, but reported in its Wednesday earnings that 12-week data are
We haven't written up this one. Endpoints News has the full story โ the link below goes straight to it.